Impact Capital Partners LLC Charles River Laboratories International, Inc. Transaction History
Impact Capital Partners LLC
- $276 Billion
- Q1 2025
A detailed history of Impact Capital Partners LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Impact Capital Partners LLC holds 2,567 shares of CRL stock, worth $348,162. This represents 0.14% of its overall portfolio holdings.
Number of Shares
2,567
Previous 2,287
12.24%
Holding current value
$348,162
Previous $422 Million
8.48%
% of portfolio
0.14%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
649Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$828 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$690 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$581 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$324 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$265 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $6.9B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...